National Institute for Clinical Excellence (NICE)
MidCity Place
71 High Holborn
London
WC1V 6NA
United Kingdom
Tel: 44-0-20-7067-5800
Fax: 44-0-20-7067-5801
Website: http://www.nice.org.uk/
Email: nice@nice.nhs.uk
169 articles about National Institute for Clinical Excellence (NICE)
-
Bristol-Myers Squibb Company, Pfizer Inc. Drug Wins National Institute for Clinical Excellence (NICE) Nod for Irregular Heartbeats
1/23/2013
-
Alimera Sciences' ILUVIEN® Receives Final Published Guidance From U.K.'s National Institute for Clinical Excellence (NICE)
1/23/2013
-
National Institute for Clinical Excellence (NICE) Backs AF Blood Pressure Device
1/18/2013
-
National Institute for Clinical Excellence (NICE) Says "No" on Pfizer Inc. Kidney Cancer Drug
12/7/2012
-
National Institute for Clinical Excellence (NICE) OKs Bristol Arthritis Drug After Price Cut
12/6/2012
-
Alimera Sciences' ILUVIEN® Receives Final Draft Guidance From U.K.'s National Institute for Clinical Excellence (NICE)
11/30/2012
-
National Institute for Clinical Excellence (NICE) Rejects Novartis AG Asthma Drug in Change of Tack
11/9/2012
-
Bristol-Myers Squibb Company Receives Positive Decision From National Institute for Clinical Excellence (NICE) for YERVOY® (ipilimumab)
11/2/2012
-
National Institute for Clinical Excellence (NICE) Stroke Guidance Boost for Boehringer Ingelheim Corporation's Actilyse
10/16/2012
-
National Institute for Clinical Excellence (NICE) U-turns on Novartis AG's Lucentis for Diabetic Macular Oedema
10/5/2012
-
Painkillers are the Cause of Headaches, National Institute for Clinical Excellence (NICE) Reveals
9/21/2012
-
pSivida Corp Reports U.K. National Institute for Clinical Excellence (NICE) Accepts ILUVIEN® Subgroup Data for Review
9/5/2012
-
Roche's Avastin Strikes Out Again With National Institute for Clinical Excellence (NICE)
8/23/2012
-
National Institute for Clinical Excellence (NICE) Bows to Industry Pressure Over Drug Appeals
8/22/2012
-
Amgen's Xgeva Gains National Institute for Clinical Excellence (NICE) Recommendation for Bone Metastasis
8/17/2012
-
National Health Service Chief Warns Over National Institute for Clinical Excellence (NICE) Drug Blacklists
8/14/2012
-
Roche Requested by National Institute for Clinical Excellence (NICE) to Provide Further Zelboraf Data
8/13/2012
-
National Institute for Clinical Excellence (NICE) Recommends New Cervical Cancer Diagnostic Test From DySIS Medical
8/3/2012
-
DySIS Medical Ltd (DySIS or the Company): National Institute for Clinical Excellence (NICE) Publishes Positive Diagnostics Guidance on DySIS Cervical Cancer Screening Product
8/1/2012
-
National Institute for Clinical Excellence (NICE) Recommends Bayer AG's Xarelto
7/25/2012